Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark

More Jobs >>

Events

Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL

More Events >>

Related Tags >> GlaxoSmithKline Merck GAVI Alliance Serum Institute of India

Panacea Biotec News

Most Popular Panacea Biotec Story

Vaccine makers cut prices for developing countries

June 9, 2011 — 6:59am ET | By Erica Teichert

Just over a week after UNICEF began publishing vaccine prices, many vaccine producers including GlaxoSmithKline and Merck have announced they will cut their vaccine prices for developing countries. Read more...

Panacea Biotec Press Releases

PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases

Latest Headlines

Vaccine makers cut prices for developing countries
June 9, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK